Introduction As a powerful bone-inducing cytokine, rhBMP-2 has been used as a bone graft substitute in combination with animal-derived collagen to achieve interbody or posterolateral spinal fusion. Successful interspinous process fusion using rhBMP-2 in combination with synthetic carrier materials would offer a safe, minimally invasive spinal fusion option for the treatment of spinal disorders. The aims of the present study were to achieve interspinous process fusion by implanting rhBMP-2-retaining degradable material instead of bone grafting and to evaluate efficacy for vertebral stabilization. Materials and methods A polymer gel (200 mg), btricalcium phosphate powder (400 mg), and rhBMP-2 (0, 30, 60 or 120 lg) were mixed to generate a plastic implant, which was then placed during surgery to bridge the L5-6 interspinous processes of 58 rabbits. Control animals received implants either without rhBMP-2 or with autogenous bone chips from the iliac crest. L5-6 vertebrae were recovered 8 weeks postoperatively. Interspinous process fusion was evaluated by radiography, biomechanical bending test, intradiscal pressure (IDP) measurement, and histology. Results In bending tests, strength of fusion was significantly greater in BMP60 and BMP120 groups than in sham, BMP0, BMP30 or autogenous bone groups. IDP at L5-6 was significantly reduced in BMP60 and BMP120 groups compared to sham, BMP0, BMP30, and autograft groups. Histologically, coronal sections of the fusion mass showed a bone mass bridging both spinous processes.
Introduction
Anterior or posterolateral spinal fusion with autogenous bone grafting has been a routine method for the treatment of spinal disorders associated with spinal instability caused by degenerative changes or trauma to the spine. Although several studies have shown satisfactory outcomes from spinal fusion for such spinal disorders, risks of complications associated with the extensive surgery remain, particularly in old patients [18, 28, 30] . In this context, development of less-invasive spinal fusion options is desirable to treat spinal disorders.
In terms of less-invasive spine surgery, the close proximity of the spinous processes to the skin allows for the implantation of interspinous process devices with minimal operative invasiveness. A large number of interspinous process devices have recently entered the market, some of which are promoted to facilitate fusion, while others are designed to preserve mobility. Interspinous process devices such as X-stop, ExtenSure, and Wallis implants have been used in operative methods for lumbar spinal stenosis in recent years. The principle underlying interspinous process devices is to unload the facet joints, restore foraminal height, and provide stability in order to improve the clinical outcomes of surgery [6] . Interspinous fixation has also been attempted to avoid the risks associated with transpedicle or sublaminar instrumentation. The most rudimentary form of interspinous fixation involves wiring the spinous processes, and the Daab plate and Wilson plate have since been developed [7, 9, 13] . Spinal instrumentation using the spinous process as an anchor offers limited flexibility [14] , but recent studies of lumbar fusion surgery using the Tadpole system and CD Horizon Spire spinous process plate Ò have shown relatively favorable clinical outcomes [19, 41] .
The concept of interspinous process fusion is a classical one and the first animal model used to study posterior interspinous spinal fusion dates back to Albee's experiments in 1913 with autogenous bone grafting in dogs [2] . Oikarinen [27] and Lindholm [23] later reported interspinous process fusion without bone autograft in rabbits. Oikarinen [27] achieved interspinous process fusion with allogeneic decalcified bone matrix. Lindholm [23] reported the combined use of allogeneic decalcified bone matrix and autogenous bone marrow with a fusion rate of 86% in 20 weeks.
However, posterior spinal fusion has rarely been indicated in clinical practice due to the high incidence of pseudoarthrosis and the long time required to obtain complete fusion even with use of adequate amount of autograft [11, 37] . To address these issues, we have introduced recombinant bone morphogenetic protein (BMP)-2 and have developed a delivery system [20, 21, 24, 34] to enhance new bone formation temporospatially and avoid surgery to procure autograft material. The properties of the delivery system as a carrier material can be listed as follows: (1) no risk of disease transfer; (2) controlled biodegradability that can effectively regulate the release of recombinant human BMPs (rhBMPs); and (3) plasticity and ease of handling [21] . The present experimental study attempted a simple and less-invasive spinal fusion of posterior interspinous processes using rhBMP-2 in combination with synthetic carrier materials without bone grafting. Solidity of the fused spinal segment was then examined using radiological, histological, and biomechanical methods. We consider that achievement of solid interspinous process fusion could reinforce biomechanical weakness in patients with vertebral fracture, disc degeneration, degenerative spondylolisthesis, spondylolytic spondylolisthesis or inter-body fusion.
Materials and methods

rhBMP-2
The Escherichia coli-derived rhBMP-2 (E-BMP-2) used in this study was produced and kindly donated by Osteopharma (Osaka, Japan) [43] . E-BMP-2 with a dimeric molecular structure was produced in human BMP-2 gene-transfected E. coli with a monomeric structure and stored in inclusion bodies, which were collected. The molecular structure was unfolded using protein-denaturing agents, and then refolded to form dimeric E-BMP-2 on removal of the denaturing agents. Dimeric E-BMP-2 was purified using several steps of chromatography. Details of the procedures for dimerization of cytokines have already been reported [12, 32, 42, 43] .
Poly-D,L-lactic acid/polyethylene glycol block copolymer (PLA-PEG) PLA-PEG (molecular weight 9,500) was provided by Taki Chemical (Kakogawa, Japan). The physicochemical characters and efficacy of the hydrogel polymer for local delivery of BMP-2 to elicit ectopic bone formation has been reported elsewhere [21] .
The b-TCP powder (particle diameter, 0.5-1.5 mm; porosity, 75%) was manufactured and provided by Olympus Optics (Tokyo, Japan).
Preparation of bone graft substitute implants
To prepare an implant (Fig. 1a) to bridge L5 and L6 interspinous processes in one animal, freeze-dried E-BMP-2 powder was dissolved in distilled water to reconstitute before use under sterile conditions. 400 mg of b-TCP powder, 200 mg of PLA-PEG, and one of three dosages of rhBMP (30, 60 , or 120 lg) were mixed by stirring with a metal rod at 50°C for several minutes to liquefy the polymer. As control implants, 400 mg of b-TCP granules and 200 mg of PLA-PEG without rhBMP-2 were prepared in the same manner. The prepared implants were stored at -30°C until implantation. We tested the heat tolerance of E-BMP-2 in a previous study and confirmed that this sterilization process does not affect the activity of rhBMP-2 [43] .
Surgery and experimental protocols
Fifty-eight Japanese white rabbits (18 weeks old; weight 2.8-3.2 kg) were divided randomly into six groups (Table 1) depending on the dose of BMP-2 in implants (BMP30, BMP60, BMP120 and BMP0), along with an autografted group and a sham-operated group. Another five rabbits died under anesthesia or during follow-up. However, no animal deaths related to materials were encountered.
Before surgery, animals were anesthetized with an intramuscular injection of ketamine (30 mg/kg) and xylazine (10 mg/kg). Cefazolin (100 mg) was administered subcutaneously as a prophylactic antibiotic. Each rabbit underwent surgery for a single level interspinous process fusion at L5-L6 level. After making a dorsal midline skin incision and a median fascial incision, the paraspinal muscles were retracted to expose the spinous processes of L5 and L6 and the interspinous ligament. An electric burr (Stryker, Kalamazoo, MI) was used to decorticate the cortex on both sides of the L5 and L6 spinous processes. The implant was a paste-like material with easy handling and molding characteristics. The volume of one implant was 0.45 ml. The paste-like implant that had been prepared as described above was placed to bridge the L5-6 interspinous processes on the interspinous ligament (Fig. 1b) . In the control group (BMP0), implants without rhBMP-2 were implanted in the same manner. For the autograft group, autogenous morselized bone harvested from iliac crest was placed. In the sham group, spinous processes were exposed, but no implant was placed. The wounds were then closed with 3-0 absorbable and 3-0 nylon sutures.
Radiological examination of L5-L6 was performed 2, 4, and 8 weeks after surgery. All animals were euthanized by overdose of anesthetics at 8 weeks after surgery, and the L4-L7 lumbar vertebrae were harvested and processed for further examination. This experimental protocol was approved by The Institutional Committee for Animal Care and Experiments at Osaka City University Medical School.
Manual palpation
Harvested lumbar spines were manually palpated by flexion and extension at the fusion level and solidity was compared with the adjacent level. Each L5-6 segment was graded as showing solid or not solid fusion. Three observers judged the results in terms of fusion. Fusion was graded as solid when the observers unanimously judged fusion to have occurred.
Intradiscal pressure (IDP) measurement
Resin (GC Ostron 2; GC, Aichi, Japan) was used to secure the L5 and L6 endplates. IDP was measured directly with a 1.6-mm-diameter needle-type pressure transducer (FOP-M; FISO Technologies, Quebec, Canada). We inserted an 18-gauge needle from the anterior surface of the annulus into the center of the disc. When the tip of the needle had penetrated the annulus fibrosus, the needle was withdrawn and the transducer tip was placed into the center of the nucleus pulposus of the L5/6 disc. An axial compression force of 0-30 N was applied on the loading board secured to the upper end of a specimen using a materials testing machine (EZ Graph; Shimadzu, Kyoto, Japan). Maximal IDP values were compared with those of control samples.
Bending test
Bending strength of the fusion mass to evaluate solidity of the L5-L6 fusion site was performed by a three-point flexionbending test using a materials testing machine (EZ Graph; Shimadzu). The L5-6 spinal segment from respective experimental and control groups was fixed to the supporting jig using resin with a 50-mm intersupport distance and bending force was applied by the load cell head at a speed of 1 mm/min. Bending moment at 1.5-mm middle-span deflection was determined from the moment deflection curves (Fig. 2) .
Histological examination
The L5-6 segments harvested from respective groups at 8 weeks after surgery were fixed in 4% paraformaldehyde overnight at 4°C, dehydrated in a graded ethanol series, and embedded in plastic resin. Coronal sections of 7 lm in thickness at the mid-part of the interspinous process were cut with a tungsten blade using a rotary microtome (RM2255; Leica Microsystems, Wetzlar, Germany) and stained with hematoxylin and eosin (HE) after decalcification with 0.5 M ethylenediaminetetraacetic acid for 30 min at room Each animal underwent histological evaluation temperature or stained with von Kossa without decalcification and observed under light microscopy (BZ-9000; Keyence, Osaka, Japan) to examine for bony fusion by newly formed bone.
Statistical analysis
Data are expressed as mean ± standard deviation for each group. Comparisons of biomechanical testing and IDP measurement of spines in each group were made using oneway analysis of variance. The Bonferroni/Dunn test was performed to determine significant differences between groups. Values of P \ 0.05 were considered statistically significant for all tests.
Results
Radiological evaluation
Radiographic images taken immediately after surgery revealed a mass of b-TCP fine particles at the operated site. At 8 weeks after surgery, radiographic images in all animals of the BMP30, BMP60, and BMP120 groups were changed to homogenous calcified shadows connecting the spinous processes. Radiographic images in animals of the BMP0 group revealed remnant b-TCP particles without a homogeneous calcified mass (Fig. 3) . No cases showed heterotopic ossification in the spinal canal.
Manual palpation
In all L5-6 spinal segments harvested from the BMP60 and BMP120 groups, bony hard masses bridging the interspinous process were palpable, and passive motion between vertebrae was significantly restricted when compared to that in the sham and BMP0 groups. Four of ten samples from the BMP30 group and two of ten samples from the autogenous bone group were evaluated as showing solid fusion. In contrast, no samples from the BMP0 or sham groups achieved solid fusion (Table 2) .
IDP measurement
IDP at the L5-6 level was significantly lower in the BMP60 and BMP120 groups than in the sham, BMP0, BMP30, and autogenous bone groups (Fig. 4) . Reduced IDP in the BMP60 group was significantly reduced by a mean of 34.9% when compared with IDP in the sham group. There are no dose effects between BMP30 and BMP60.
Bending test
Results from bending strength measurements in each experimental group are shown in Fig. 5 . Bending moment at 1.5-mm middle span deflection was significantly greater in the BMP60 and BMP120 groups than in the sham, BMP0, BMP30 or autogenous bone groups. The BMP30 group showed significantly greater bending moment than the sham and BMP0 groups. There are no dose effects between BMP30 and BMP60.
Histology
Coronal sections of the L5-6 interspinous fusion mass in animals that received rhBMP-2 (60 or 120 lg) showed new bone bridging the spinous processes with characteristics of woven bone with hematopoietic marrow. In animals that did not receive rhBMP-2 (BMP0), only fibrous tissue and remaining b-TCP without new bone were observed (Fig. 6) . No cases showed heterotopic ossification in the spinal canal or robust inflammation.
Discussion
To manufacture an osteoinductive artificial bone graft substitute, cytokines retaining osteoinductive activity (e.g., BMPs) have been combined with collagen and used to obtain spinal fusion in experimental animals or in human cases [1, 4, 5, 17, 25, 26, 35, 36] . This experimental study was designed to achieve solid posterior interspinous lumbar fusion more effectively and less invasively than before with proper use of rhBMP-2 in combination with synthetic carrier materials. BMPs are biologically active molecules capable of eliciting new bone formation. In combination with biomaterials, these proteins can be used in clinical settings as bone-graft substitutes to promote bone repair. Collagen from animal sources has previously been the preferred carrier material in animal experiments. However, problems remain with the use of animal-derived collagen, including the risk of antibody generation or disease transmission and lack of mechanical strength of the carrier collagen [3, 8, 10] . To overcome these problems, synthetic biodegradable polymers have recently been tested as a delivery vehicle for osteoinductive agents. Earlier studies performed in our laboratory found that the PLA-PEG block copolymer with plastic properties works effectively as a BMP delivery system [33, 34] . We then attempted to development a new biodegradable bone-inducing material by adding rhBMP-2 to porous b-TCP granules using a PLA-PEG polymer delivery system. The purpose of adding porous b-TCP powder was to increase the plasticity of the polymer for ease of handling, increase induced bone yields by volume expansion of the rhBMP-2-containing polymer implants and subsequently improve performance of the rhBMP-2. This new bone-inducing biodegradable porous b-TCP might provide effective artificial bone-graft substitutes with osteoinductive capacity and biodegradable properties [20, 26] . At the same time, reducing the cost of production for rhBMP-2 is important if clinical use is to become widespread. Currently, rhBMPs are produced using BMP gene-transfected mammalian cell (CHO) cultures [16, 40] . However, production costs are very high due to the low performance efficiency of current technologies for purifying recombinant BMPs produced by mammalian cells. One possible solution to this problem is high-efficiency, lowcost production of monomer rhBMPs in BMP-gene-transfected E. coli and conversion of the monomer rhBMPs to dimeric rhBMP using ex vivo biochemical processing. The ectopic induction of new bone formation by dimeric E-BMP-2 has already been reported elsewhere [22, 32] . Recent studies in our laboratory found that characteristics of E-BMP-2 are satisfactory for clinical use to promote bone healing in place of the currently available BMP-2 produced by BMP-2-expressing CHO cells [12, 43] . We therefore consider that achievement of solid interspinous process fusion using this new biodegradable bone-inducing material could address biomechanical weakness in spinal disorders as a less-invasive option without bone grafting. The carrier material for BMP-2, a composite of PLA-PEG hydrogel and b-TCP powder, was developed by our group and its efficacy as a BMP-2 carrier has been confirmed in several experimental animal models of various bone defects and spinal fusions [15, 26] . With the use of equivalent amounts of carrier material, the BMP-2-induced new bone mass at the interspinous process region appeared to depend on the BMP-2 dose, and the optimal dose for consistent, solid posterior fusion was 60-120 lg of BMP-2 in 600 mg of carrier for this rabbit model. However, responsiveness to BMP-2 is known to vary widely depending on the animal species, with high responsiveness in rodents and lower responsiveness in higher mammals [21, 39] . Much higher doses of BMP-2 in addition to a larger amount of carrier material are thus likely to be essential in achieving solid posterior spinal fusion for nonhuman primates and humans. Optimal doses in a clinical setting should be set based on results for experimental posterior spinal fusion with BMP-2 and synthetic carrier materials in large animals or primates and ultimately from future clinical trials.
This new and simple technology to obtain solid posterior spinal fusion in a short period might present a potential solution to the disadvantages of current techniques for spinal fusion of posterior interspinous processes. With regard to mechanical strength of the fusion mass, significant solidity was noted at 8 weeks after surgery, but this study could not elucidate whether the mechanical strength of the fusion mass is subsequently maintained or remodeled to a stronger bone mass under mechanical stress. IDP after the completion of posterior fusion was reduced to around 65% of the original intact value, meaning that elasticity of the disc was partially retained, as reported previously for posterolateral fusion (PLF) [31] . The remaining elasticity of the disc might reduce the risk of degeneration in discs adjacent to the fused segment, which is often encountered after inter-body fusion [28, 29, 38] .
We note several limitations. The first drawback of this study was the use of normal young rabbits with intact spines. If we had used aged rabbits or rabbit with disc degeneration, the results might have differed and consistent solid fusion might not have been obtained using the present methods. The possibility remains that a higher BMP-2 dose might have been required to achieve solid posterior spinal fusion. Another experimental model with segmental instability in the lumbar spine should be used in the next series of studies to clarify the efficacy of BMP-2-retaining bone graft substitute for spinal fusion. Second, we did not compare the interspinous process fusion model with a PLF model in terms of the effective dose of E-BMP-2. Our previous study reported that the effective dose of E-BMP-2 for a rabbit PLF model was 50 lg [12] . In the present preliminary study, we were able to achieve solid interspinous process fusion using E-BMP-2, but the differences in effective dose for these two models remain unclear. Future studies should evaluate the safety, advantages, invasiveness, and cost-effectiveness of this new approach compared with a PLF model. Third, we have reported the release of BMP-2 in other experimental models, but did not assess the in vitro release of BMP-2 in this model of interspinous process fusion. Subsequent serial experimental studies are necessary to develop new, simple, safe, and efficacious methods for spinal fusion before considering application to future clinical practice.
Conclusion
Interspinous process fusion was successfully achieved within 8 weeks in a rabbit model with synthetic bone graft substituting materials (PLA-PEG, rhBMP-2, and b-TCP).
The fusion rate with this method was superior to that with autogenous bone grafting. This new method might potentially contribute to the development of simple and safe surgery to stabilize unstable segments of the spine, although extensive studies are necessary before practical use in spine surgery. lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. 
